Clincosm LogoSign in Get a demo

Ocular Hypertension

Showing NaN - NaN of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham Bimatoprost SR, Selective Laser

Active, not recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Bimatoprost SR
  • +3 more
  • Dothan, Alabama
  • +94 more
Nov 1, 2022

Ocular Hypertension Trial in Philadelphia (ST266 via Intranasal Delivery)

Completed
  • Ocular Hypertension
  • ST266 via Intranasal Delivery
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 22, 2022

Glaucoma, Glaucoma Suspect, Diabetic Retinopathy Trial in Philadelphia (Free Eye Screenings, Enhanced Intervention, Usual Care)

Completed
Has Results
  • Glaucoma
  • +12 more
  • Free Eye Screenings
  • +2 more
  • Philadelphia, Pennsylvania
    Wills Eye Glaucoma Service
Aug 19, 2022

Glaucoma, Ocular Hypertension Trial in Colombia, United States (Bimatoprost Ophthalmic)

Recruiting
  • Glaucoma
  • Ocular Hypertension
  • Bimatoprost Ophthalmic
  • Philadelphia, Pennsylvania
  • +7 more
Jul 18, 2022

MIGS and Traditional Surgeries

Enrolling by invitation
  • Glaucoma
  • Ocular Hypertension
    • Philadelphia, Pennsylvania
      Wills Eye Hospital
    Mar 25, 2022

    Primary Open Angle Glaucoma, Ocular Hypertension Trial in United States (DE-126 Ophthalmic Solution 0.002% QD, Timolol Maleate

    Completed
    • Primary Open Angle Glaucoma
    • Ocular Hypertension
    • DE-126 Ophthalmic Solution 0.002% QD
    • Timolol Maleate Ophthalmic Solution 0.5% BID
    • Chandler, Arizona
    • +40 more
    Feb 10, 2022

    Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham: Applicator Without Needle, Active

    Completed
    Has Results
    • Glaucoma, Open-Angle
    • Ocular Hypertension
    • Bimatoprost SR
    • +3 more
    • Dothan, Alabama
    • +112 more
    Jul 6, 2021

    Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (PF-04217329 - Lowest Dose, PF-04217329 - Low Dose,

    Completed
    Has Results
    • Primary Open-Angle Glaucoma
    • Ocular Hypertension
    • PF-04217329 - Lowest Dose
    • +8 more
    • Artesia, California
    • +22 more
    Apr 6, 2021

    Open Angle Glaucoma, Ocular Hypertension Trial in United States (Xalacom, Xalatan, Timolol)

    Completed
    • Open Angle Glaucoma
    • Ocular Hypertension
    • Birmingham, Alabama
    • +63 more
    Feb 17, 2021

    Ocular Hypertension, Glaucoma Trial in Philadelphia (Massage, Experimental insert, Sham insert)

    Completed
    • Ocular Hypertension
    • Glaucoma
    • Massage
    • +2 more
    • Philadelphia, Pennsylvania
      Temple University Hospital Ophthalmology Clinic
    Feb 2, 2021

    Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Active Comparator: Timolol 0.5%, Sham: Applicator

    Completed
    Has Results
    • Glaucoma, Open-Angle
    • Ocular Hypertension
    • Bimatoprost SR
    • +3 more
    • Phoenix, Arizona
    • +105 more
    May 29, 2020

    Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (bimatoprost 20 µg generation 2, bimatoprost 15 µg generation 2,

    Completed
    Has Results
    • Open-Angle Glaucoma
    • Ocular Hypertension
    • bimatoprost 20 µg generation 2
    • +6 more
    • Artesia, California
    • +56 more
    Mar 27, 2020

    Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic

    Completed
    Has Results
    • Ocular Hypertension
    • Open Angle Glaucoma
    • AR-13324 Ophthalmic Solution 0.01%
    • +3 more
    • Newport Beach, California
    • +10 more
    Mar 19, 2018

    Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic

    Completed
    Has Results
    • Ocular Hypertension
    • Open Angle Glaucoma
    • AR-13324 Ophthalmic Solution 0.01%
    • +2 more
    • Artesia, California
    • +21 more
    Mar 19, 2018

    Glaucoma, Ocular Hypertension Trial in Willingboro, Philadelphia (ibuprofen, latanoprost, brimonidine, Ibuprofen, brimonidine,

    Completed
    • Glaucoma
    • Ocular Hypertension
    • ibuprofen, latanoprost, brimonidine
    • +2 more
    • Willingboro, New Jersey
    • +2 more
    Apr 3, 2018

    Glaucoma, Ocular Hypertension Trial in Philadelphia, London (Preservative free tafluprost opthalmic solution)

    Completed
    • Glaucoma
    • Ocular Hypertension
    • Preservative free tafluprost opthalmic solution
    • Philadelphia, Pennsylvania
    • +1 more
    Oct 9, 2017

    Ocular Hypertension, Open-Angle Glaucoma Trial in United States (Latanoprost Punctal Plug Delivery System (L-PPDS))

    Completed
    • Ocular Hypertension
    • Open-Angle Glaucoma
    • Latanoprost Punctal Plug Delivery System (L-PPDS)
    • Chandler, Arizona
    • +17 more
    Jan 16, 2017

    Ocular Hypertension, Open Angle-glaucoma Trial in United States (ONO-9054, Latanoprost)

    Completed
    • Ocular Hypertension
    • Open Angle-glaucoma
    • Los Angeles, California
    • +11 more
    Jan 26, 2016

    Open-angle Glaucoma, Ocular Hypertension Trial in United States (High Dose Drug Device, Low Dose Drug Device, Placebo Device)

    Completed
    Has Results
    • Open-angle Glaucoma
    • Ocular Hypertension
    • High Dose Drug Device
    • +3 more
    • Miami, Florida
    • +4 more
    Feb 18, 2015

    Glaucoma, Ocular Hypertension Trial in United States (Latanoprost 0.005%, AR-12286 Ophthalmic Solution 0.5%, Timolol maleate

    Completed
    • Glaucoma
    • Ocular Hypertension
    • Latanoprost 0.005%
    • +2 more
    • New Haven, Connecticut
    • +14 more
    Apr 18, 2014

    Glaucoma, Ocular Hypertension Trial in United States (Latanoprost-PPDS)

    Completed
    • Glaucoma
    • Ocular Hypertension
    • Artesia, California
    • +7 more
    Sep 16, 2013

    Open-Angle Glaucoma, Ocular Hypertension Trial in United States (DE-104 ophthalmic solution, low concentration, DE-104

    Completed
    • Open-Angle Glaucoma
    • Ocular Hypertension
    • DE-104 ophthalmic solution, low concentration
    • +4 more
    • Artesia, California
    • +13 more
    Nov 1, 2011

    Glaucoma, Open Angle Glaucoma, Ocular Hypertension Trial in United States (PhXA41, timolol)

    Completed
    • Glaucoma
    • +2 more
    • La Jolla, California
    • +16 more
    Mar 24, 2011

    Open Angle Glaucoma, Ocular Hypertension, Pseudoexfoliation Syndrome Trial in United States (Travatan, Azopt, Alphagan P)

    Completed
    • Open Angle Glaucoma
    • +2 more
    • Los Angeles, California
    • +20 more
    Feb 22, 2006